miRNAtarget™ project: open for out-licensing and/or co-development partnership
Summary of invention:
Several miRNA compounds for cytoprotection in ischemic diseases, method of identification for cytoprotective miRNA targets, termed "protectomiRs".
- Patented technology (primary filing date Aug, 2011)
- miRNAtarget, protectomiR, pathomiR, therapomiR, toxicomiR, and diagnomiR are trademarks of Pharmahungary
Potential investors and/or co-development partners, please contact us for further details at
(Please manually type the e-mail address in your e-mail client.)